Save 20% on Press Releases and More with NNW Prime! Click to View Details
WednesdayOct 18, 2017 1:28 pm

NetworkNewsBreaks – Your Electric Vehicle Could Soon Be Powered by Lithium from 92 Resources Corp.’s (TSX.V: NTY) (OTCQB: RGDCF) (FSE: R9G2) Properties

Consumers are getting increasingly comfortable with the idea of electric vehicles (EVs), which, it has been predicted, could reach 200,000 units sold to Americans this year. Increasing EV sales has also meant increased demand for automotive batteries and the lithium powering them—making the lithium properties held by 92 Resources Corp. (TSX.V: NTY) (OTCQB: RGDCF) (FSE: R9G2) increasingly important. An article discussing this reads: “As stock prices of the senior mining companies fully encapsulate the promising outlook for lithium, it is only a matter of time before the attention turns to junior exploration companies like 92 Resources. The company presently holds…

Continue Reading

WednesdayOct 18, 2017 1:25 pm

NetworkNewsBreaks – SinglePoint, Inc. (SING) CEO Featured in Equities.com Interview

SinglePoint (OTC: SING) was featured in an article published by Equities.com in which the company’s chief executive officer, Greg Lambrecht, was interviewed. SinglePoint is a full-service mobile technology provider focused on horizontal markets and acquiring undervalued subsidiaries. The company is currently engaged in two booming industries: cannabis and cryptocurrency. “We believe that when we get through with our cryptocurrency product we're going to have a huge first mover advantage to be able to go into the dispensary and let the customers use Bitcoin or other coins to pay for cannabis. It’s just a huge opportunity and with our technical expertise…

Continue Reading

WednesdayOct 18, 2017 1:23 pm

NetworkNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Attains CE Mark for Smart Glucose Meter on Latest Apple (NASDAQ: AAPL) Devices; Shares Rise

Shares of DarioHealth (NASDAQ: DRIO) are up 40.5% following the company’s news this morning that it has received the CE Mark for its Lightning®-enabled version of the Dario™ Blood Glucose Monitoring System. This ensures that consumers in the UK are able to continue to use the company’s services on the latest Apple (NASDAQ: AAPL) devices. Upon receiving the CE Mark, the company can now offer its proprietary meter with either a 3.5mm headphone jack or a Lightning connector. "We are proud that our organization worked with agility to ensure connectivity to the latest Apple devices. This significant milestone will allow…

Continue Reading

WednesdayOct 18, 2017 1:21 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on October 18, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: CNET 9.33% – News: 28.com subsidiary releases update for mobile app LPCN 8.89% – News: FDA schedules advisory committee for TLANDO™ on January 10 TROV 8.86% – News: Reports positive preclinical data on PCM-075 with Zytiga® APWC 5.26% – News: Declares cash dividend YIPI 5.00% – News: Becomes primary vendor for enterprise search and discovery for Digital Federal Credit Union HPJ 4.35% – News: Names new independent director FTXP 3.13% – News: Acquires 21%…

Continue Reading

WednesdayOct 18, 2017 11:27 am

NetworkNewsBreaks – Pressure BioSciences, Inc. (PBIO) Enters Collaboration Agreement with Phasex Corporation

Pressure BioSciences, Inc. (“PBI”) (OTCQB: PBIO), a leader in the development and sale of innovative solutions for the worldwide life sciences industry, this morning announced a collaboration with Phasex Corporation, one of the world’s most experienced supercritical fluid (“SCF”)-based toll processors. The goal of the collaboration is to combine PBI’s recently patented Ultra Shear Technology with Phasex’s SCF-based processing methods to enable the development of stable, water-soluble nanoemulsions of nutraceuticals, including CBD-enriched plant oil. “Rapidly expanding markets for non-psychoactive extracts of cannabis plant material, for instance, is an example of a potentially high demand application for our combined, synergistic technologies,” Richard…

Continue Reading

WednesdayOct 18, 2017 10:40 am

NetworkNewsBreaks – EVIO, Inc. (EVIO) Announces Strong Start to Fiscal 2018

EVIO, Inc. (OTCQB: EVIO), a leading provider of cannabis analytical testing services, this morning announced that its EVIO Labs division has already exceeded last October’s testing revenues through the first half of October 2017, with sales surpassing $250,000. “Our national sales team continues to expand EVIO's service offerings,” William Waldrop, CEO of EVIO, stated in the news release. “After an impressive 2017, in which we exceeded our own internal projections, we are starting the 2018 fiscal year on the right track. We are eagerly waiting for the upcoming accreditation of our new pesticide equipment. As mentioned in our 8K, the…

Continue Reading

WednesdayOct 18, 2017 10:06 am

NetworkNewsBreaks – Greenkraft, Inc. (GKIT) Announces California Clean Air Act Certification for Alternative Fuel Engine

Greenkraft, Inc. (OTCQB: GKIT), a nationally recognized player in the alternative fuel engine and vehicle market, this morning announced that its 8L V8 Gasoline, CNG, and LPG fuel-injected engine received new certification from the California Air Resources Board’s “On-Road New Vehicle and Engine Certification Program.” In order to earn certification under this program, vehicles must demonstrate that exhaust and evaporative emission controls systems are durable and comply with the emission standards for the vehicle’s useful life. Greenkraft’s 8L V8 fuel-injected engine achieved a NOx emission value of less than 0.02 g/bhp-hr, meeting the California Air Resource Board’s optional near-zero NOx…

Continue Reading

WednesdayOct 18, 2017 9:30 am

NetworkNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Approaching Commercialization of IGC-AD1 in Early 2018

India Globalization Capital, Inc. (NYSE American: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning provided compelling in vitro data compiled from genetically engineered cell lines within an Alzheimer’s disease model showing that, at varying concentrations of IGC-AD1, the expression of GSK3β is reduced by as much as 62 percent. “Based on this and other previously announced compelling data, we are readying IGC-AD1, brand name Hyalolex, in a liquid formulation for commercialization in early 2018,” Ram Mukunda, CEO of IGC, stated in the news release. “We have identified Germany, Canada and certain licensed medical…

Continue Reading

TuesdayOct 17, 2017 12:33 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on October 17, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: NEOT 100.13% – News: Enters merger agreement with Evofem Biosciences, Inc. to create women's health company INSG 9.56% – News: Moves on momentum from recent collaboration deal AMDA 5.60% – News: Receives listing extension from Nasdaq BLSP 4.74% – News: Posts shareholder update DRNE 4.17% – News: Secures contract with U.S. Department of Defense for WASP system MYSZ 3.88% – News: Adds Susan Moses and supermodel Emme to team ASRV 3.85% – News: Posts…

Continue Reading

TuesdayOct 17, 2017 12:29 pm

NetworkNewsBreaks – Diffusion Pharmaceuticals, Inc. (NASDAQ: DFFN) Shares Surge after Receiving Final FDA Protocol Guidance for TSC Phase 3 Clinical Trial

Shares of Diffusion Pharmaceuticals, Inc. (NASDAQ: DFFN) are up 35.4% this morning after the company said it has received final protocol guidance from the U.S. Food and Drug Administration (FDA) for a phase 3 clinical trial with trans sodium crocetinate (TSC) in patients newly diagnosed with inoperable glioblastoma multiforme (GBM), a type of brain cancer. The trial will compare survival at two years of patients receiving the company’s lead compound TSC with chemotherapy and radiation (standard of care), with patients receiving the standard of care alone. Diffusion intends to begin the trial under the protocol agreed upon by the FDA…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000